SCHEDULE: Millennium Management Discloses Stake in Cabaletta Bio

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 1.3% of Cabaletta Bio, Inc.'s common stock as of June 30, 2026.

Summary

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly filed a Schedule 13G, indicating their beneficial ownership of Cabaletta Bio, Inc. common stock.
• The filing, amended as of July 22, 2026, covers the ownership as of June 30, 2026.
• The reporting persons collectively beneficially own 2,068,491 shares of common stock.
• This represents 1.3% of the class of securities outstanding.
• The shares are held by entities subject to the voting control and investment discretion of Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Mr. Englander.
• The filing clarifies that this is not an admission of beneficial ownership by the named entities themselves.
• The reporting persons certify that the securities were not acquired or held for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It's a standard disclosure of ownership by an investment firm and does not inherently provide new operational or financial information about the company itself.

Positives

• Millennium Management's investment indicates confidence in Cabaletta Bio's potential.
• The disclosure is a standard regulatory filing, providing transparency to the market.

Negatives

• The filing does not contain any negative financial or operational information about Cabaletta Bio itself, as it is a disclosure of ownership by a third party.

Risks

• The filing does not explicitly mention risks related to Cabaletta Bio's operations or financial health.
• Potential future changes in Millennium Management's stake could impact the stock price.

Future Outlook

The filing does not contain forward-looking statements or guidance from Cabaletta Bio. It is a disclosure of beneficial ownership by Millennium Management.

Management Comments

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander confirm their agreement to jointly file the Schedule 13G.
• Gil Raviv, Global General Counsel for Millennium Management LLC and Millennium Group Management LLC, signed the filing.
• Israel A. Englander signed the filing as an individual reporting person.

Industry Context

StockSavvy.ai notes that significant institutional ownership filings like this can signal investor interest and potentially influence market perception of Cabaletta Bio's stock.

Stakeholder Impact

• Shareholders: Increased transparency regarding significant ownership stakes.
• Management of Cabaletta Bio: Awareness of a substantial institutional investor.
• Market Participants: Information for trading and investment decisions.

Next Steps

• Cabaletta Bio, Inc. will continue its operations as disclosed in its other filings.
• Millennium Management LLC will continue to manage its investment in Cabaletta Bio, Inc.

Key Dates

Keywords

Cabaletta Bio, Millennium Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, Securities Exchange Act